Ganorkar
Kirti Ganorkar, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20130288994 | READY TO BE INFUSED GEMCETABINE SOLUTION - A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused. | 10-31-2013 |
Kirti Ganorkar, Baroda IN
Patent application number | Description | Published |
---|---|---|
20160058663 | PERFUSION DOSAGE FORM - The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. | 03-03-2016 |
Kirti Wardhaman Ganorkar, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20110250271 | SPACED DRUG DELIVERY SYSTEM - The present invention provides to a method of administration of two or more therapeutically active agents comprising orally administering to a patient a spaced drug delivery system, wherein the time of release of the two or more therapeutically active agents is designed to provide desired control on the disease condition. The present invention also provides a method of administration of two or more therapeutically active agents comprising orally administering to a patient a spaced drug delivery system at a specified time prior to food intake by the patient. The present invention further provides a spaced drug delivery system that releases two or more antidiabetic agents at different times after oral administration, for the treatment of diabetes mellitus or conditions associated with diabetes mellitus. More particularly, the present invention provides a spaced drug delivery system that immediately releases one or more antidiabetic agents after oral administration of the system, and releases as a pulse one or more antidiabetic agents in a reliable manner at about a predetermined time after oral administration of the system. | 10-13-2011 |
Loksidh D. Ganorkar, Kalamazoo, MI US
Patent application number | Description | Published |
---|---|---|
20090143387 | SUSTAINED-RELEASE TABLET COMPOSITION - A sustained-release pharmaceutical composition in a form of an orally deliverable tablet containing reboxetine, or a pharmaceutically acceptable salt thereof, dispersed in a matrix containing a hydrophilic polymer and a starch, wherein the starch has a tensile strength of at least 0.15 kN cm | 06-04-2009 |
Loksidh Devi Ganorkar, Kalamazoo, MI US
Patent application number | Description | Published |
---|---|---|
20100316710 | SUSTAINED-RELEASE TABLET COMPOSITION OF PRAMIPEXOLE - A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cm | 12-16-2010 |
Rakesh Ganorkar, Mortsel BE
Patent application number | Description | Published |
---|---|---|
20160024030 | PROCESS FOR PRODUCING 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID AND COMPLEXES THEREOF - A process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) including salts and hydrates thereof of general formula (I) from the respective cyclen. | 01-28-2016 |